We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M Turnover 22.64%
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
-0.82%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$927M
AUM Growth
-$1.43M
Cap. Flow
+$7.24M
Cap. Flow %
0.78%
Top 10 Hldgs %
60.5%
Holding
125
New
10
Increased
26
Reduced
9
Closed
9
Avg Time Held
2.1 years
Top 10 Avg Time Held
2.3 years
Top 20 Avg Time Held
2.3 years

Top Sells

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$9.37M
2
WAB icon
Wabtec
WAB
+$5.68M
3
PG icon
Procter & Gamble
PG
+$4.97M
4
GIS icon
General Mills
GIS
+$3.54M
5
CELG
Celgene Corp
CELG
+$3.18M

Sector Composition

Rank Sector Weight
1 Financials 39.92%
2 Healthcare 20.06%
3 Miscellaneous 11.58%
4 Industrials 8.62%
5 Materials 6.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BUD icon
26
AB InBev
BUD
$160B
$8.92M 0.96%
93,700
-30,100
-24% -$2.86M
2015 Q3
16 quarters
MDT icon
27
Medtronic
MDT
$122B
$8.33M 0.9%
76,700
– –
2014 Q1
22 quarters
ASHR icon
28
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.34B
$7.36M 0.79%
271,680
+8,640
+3% +$238K
2017 Q2
9 quarters
USB icon
29
US Bancorp
USB
$89.4B
$7.05M 0.76%
127,370
+1,800
+1% +$97.3K
2016 Q2
13 quarters
GE icon
30
GE Aerospace
GE
$324B
$7.01M 0.76%
157,440
-64,123
-29% -$3.01M
2017 Q4
7 quarters
AMGN icon
31
Amgen
AMGN
$235B
$6.51M 0.7%
33,650
– –
2015 Q4
15 quarters
VDC icon
32
Vanguard Consumer Staples ETF
VDC
$7.93B
$6.36M 0.69%
40,600
– –
2018 Q2
5 quarters
PG icon
33
Procter & Gamble
PG
$365B
$6.25M 0.67%
50,250
-42,100
-46% -$4.97M
2018 Q2
5 quarters
BDX icon
34
Becton Dickinson
BDX
$52.8B
$6.06M 0.65%
24,569
– –
2014 Q1
22 quarters
GILD icon
35
Gilead Sciences
GILD
$195B
$5.34M 0.58%
84,220
– –
2014 Q4
19 quarters
CSCO icon
36
Cisco
CSCO
$433B
$5.13M 0.55%
103,900
– –
2014 Q1
22 quarters
GOOG icon
37
Alphabet (Google) Class C
GOOG
$4.22T
$4.75M 0.51%
78,000
– –
2014 Q1
22 quarters
VWO icon
38
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$4.75M 0.51%
117,910
+17,300
+17% +$714K
2017 Q2
9 quarters
CI icon
39
Cigna
CI
$79B
$4M 0.43%
26,316
– –
2017 Q2
9 quarters
BIIB icon
40
Biogen
BIIB
$34.8B
$3.29M 0.36%
14,130
– –
2015 Q4
15 quarters
IBB icon
41
iShares Biotechnology ETF
IBB
$10.6B
$3.23M 0.35%
32,510
– –
2018 Q1
6 quarters
HDV icon
42
iShares Core High Dividend ETF
HDV
$15.4B
$3.21M 0.35%
170,350
+24,400
+17% +$459K
2018 Q2
5 quarters
IBM icon
43
IBM
IBM
$221B
$3.08M 0.33%
22,186
-1,569
-7% -$212K
2014 Q1
22 quarters
SRCL icon
44
DELISTED
Stericycle Inc
SRCL
$3.02M 0.33%
59,400
– –
2015 Q1
18 quarters
MA icon
45
Mastercard
MA
$540B
$2.72M 0.29%
10,000
– –
2014 Q1
22 quarters
AKTX icon
46
Akari Therapeutics
AKTX
$20.2M
$2.56M 0.28%
1,875
+125
+7% +$191K
2017 Q2
9 quarters
KO icon
47
Coca-Cola
KO
$396B
$2.5M 0.27%
46,000
– –
2014 Q1
22 quarters
DVA icon
48
DaVita
DVA
$12.1B
$2.42M 0.26%
42,420
– –
2014 Q1
22 quarters
VB icon
49
Vanguard Morningstar Small-Cap ETF
VB
$77.9B
$2.23M 0.24%
14,500
+2,940
+25% +$456K
2019 Q1
2 quarters
RTX icon
50
RTX Corp
RTX
$252B
$2.04M 0.22%
23,756
– –
2014 Q1
22 quarters

Similar funds

Hikari Power's Q3 2019 Portfolio in Review

As of Q3 2019, Hikari Power held 125 positions worth $927M, down 0.15% from $928M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Hikari Power's Q3 2019 filing shows 10 new, 26 increased, 9 reduced and 9 closed positions. Its largest new stake was State Street SPDR Portfolio Short Term Treasury ETF: 376,500 shares worth $11.3M. The largest sale was Colgate-Palmolive, an estimated $9.37M.

By sector, the portfolio is most concentrated in Financials at 40% of assets, up from 38% a quarter earlier, followed by Healthcare and Miscellaneous.

  • Hikari Power's largest Q3 2019 buy was State Street SPDR Portfolio Short Term Treasury ETF: 376,500 shares worth $11.3M.
  • Hikari Power added most to Wells Fargo in Q3 2019, an estimated $9.14M increase.
  • Hikari Power's biggest Q3 2019 reduction was Colgate-Palmolive, cutting an estimated $9.37M.
  • Hikari Power fully exited Acadia Pharmaceuticals in Q3 2019, selling an estimated $495K.
  • Hikari Power's ten largest holdings make up 61% of its $927M portfolio in Q3 2019.
  • Hikari Power opened 10 new positions and closed 9 in Q3 2019.
  • Hikari Power's portfolio value fell 0.15% quarter-over-quarter to $927M.

Based on Hikari Power's 13F filing for Q3 2019, filed 31 Oct 2019.